Molecular profiling: moving away from tumor philately.
Despite the remarkable enhancements in breast cancer classification and characterization, an exhaustive comprehension of the underlying carcinogenic processes and an accurate prediction of its clinical behavior are yet to be achieved. On the wave of recent scientific advances and clinical findings, new cutting-edge technologies are poised to deliver an array of diverse molecular data that are expected to dramatically alter breast cancer diagnosis and treatment.
Reis-Filho
Jorge S
JS
Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK. jorge.reis-filho@icr.ac.uk
Weigelt
Britta
B
Fumagalli
Debora
D
Sotiriou
Christos
C
D014408:Biomarkers, Tumor / Q000235:genetics; D001943:Breast Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000503:physiopathology* / Q000628:therapy; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D009369:Neoplasms / Q000145:classification* / Q000235:genetics; D011379:Prognosis
D014408:Biomarkers, Tumor